Cytori Therapeutics, Inc. (CYTX) Reports In-Line Q1 Loss of 16c/Share

Cytori Therapeutics, Inc. (NASDAQ: CYTX) reported Q1 EPS of ($0.16), in-line with the analyst estimate of ($0.16). Revenue for the quarter came in at $1.48 million, versus $1.36 million reported last year.

For earnings history and earnings-related data on Cytori Therapeutics, Inc. (CYTX) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• DeFi Technologies Inc. (DEFT) Reports Q2 Loss of $0.04
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79